| leukocyte differentiation | GO:0002521 | 342 | 0.250 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.248 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.167 | |
| t cell differentiation | GO:0030217 | 174 | 0.143 | |
| muscle system process | GO:0003012 | 141 | 0.114 | |
| blood circulation | GO:0008015 | 195 | 0.107 | |
| ossification | GO:0001503 | 216 | 0.106 | |
| chromatin organization | GO:0006325 | 206 | 0.104 | |
| regulation of system process | GO:0044057 | 200 | 0.099 | |
| circulatory system process | GO:0003013 | 197 | 0.097 | |
| macromolecule methylation | GO:0043414 | 120 | 0.096 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.093 | |
| response to vitamin d | GO:0033280 | 3 | 0.092 | |
| regulation of defense response | GO:0031347 | 233 | 0.090 | |
| skeletal system development | GO:0001501 | 356 | 0.090 | |
| learning or memory | GO:0007611 | 148 | 0.086 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.082 | |
| stem cell differentiation | GO:0048863 | 268 | 0.080 | |
| telomere maintenance | GO:0000723 | 19 | 0.080 | |
| mapk cascade | GO:0000165 | 281 | 0.077 | |
| t cell activation | GO:0042110 | 289 | 0.070 | |
| positive regulation of growth | GO:0045927 | 104 | 0.069 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.068 | |
| heart contraction | GO:0060047 | 93 | 0.064 | |
| appendage development | GO:0048736 | 166 | 0.063 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.063 | |
| chemotaxis | GO:0006935 | 247 | 0.060 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.059 | |
| bone development | GO:0060348 | 120 | 0.059 | |
| regulation of secretion | GO:0051046 | 274 | 0.058 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.057 | |
| camera type eye development | GO:0043010 | 266 | 0.057 | |
| methylation | GO:0032259 | 134 | 0.056 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.056 | |
| regionalization | GO:0003002 | 337 | 0.055 | |
| gland development | GO:0048732 | 330 | 0.053 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.052 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.052 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.051 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.051 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.051 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.050 | |
| monocyte differentiation | GO:0030224 | 9 | 0.050 | |
| heart process | GO:0003015 | 94 | 0.049 | |
| gene silencing | GO:0016458 | 38 | 0.049 | |
| bone morphogenesis | GO:0060349 | 78 | 0.049 | |
| protein processing | GO:0016485 | 163 | 0.048 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.047 | |
| dna metabolic process | GO:0006259 | 303 | 0.047 | |
| olfactory learning | GO:0008355 | 2 | 0.047 | |
| cognition | GO:0050890 | 149 | 0.046 | |
| axon guidance | GO:0007411 | 141 | 0.045 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.045 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.045 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.045 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.043 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.042 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.042 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.042 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.042 | |
| organelle localization | GO:0051640 | 179 | 0.041 | |
| stem cell development | GO:0048864 | 219 | 0.041 | |
| histone modification | GO:0016570 | 159 | 0.040 | |
| muscle tissue development | GO:0060537 | 308 | 0.040 | |
| organelle assembly | GO:0070925 | 177 | 0.040 | |
| organ growth | GO:0035265 | 117 | 0.040 | |
| nuclear division | GO:0000280 | 158 | 0.040 | |
| forebrain development | GO:0030900 | 302 | 0.039 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.039 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.039 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.039 | |
| gonad development | GO:0008406 | 141 | 0.039 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.039 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.038 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.038 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.038 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.037 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.037 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.037 | |
| limb morphogenesis | GO:0035108 | 149 | 0.036 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.036 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.036 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.036 | |
| germ cell development | GO:0007281 | 185 | 0.036 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.035 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.035 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.034 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.034 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.034 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.034 | |
| female gamete generation | GO:0007292 | 74 | 0.034 | |
| somite development | GO:0061053 | 81 | 0.033 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.033 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.033 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.033 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.033 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.033 | |
| memory | GO:0007613 | 58 | 0.033 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.033 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.033 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.033 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.032 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.032 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.032 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.032 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.031 | |
| protein polymerization | GO:0051258 | 57 | 0.031 | |
| somitogenesis | GO:0001756 | 69 | 0.031 | |
| regulation of protein localization | GO:0032880 | 231 | 0.031 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.030 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.030 | |
| multicellular organism growth | GO:0035264 | 161 | 0.030 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.029 | |
| cation homeostasis | GO:0055080 | 212 | 0.029 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.029 | |
| digestive system development | GO:0055123 | 200 | 0.029 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.029 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.029 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.029 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.028 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.028 | |
| amine metabolic process | GO:0009308 | 45 | 0.028 | |
| respiratory system development | GO:0060541 | 190 | 0.028 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.028 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.028 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.028 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.028 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.028 | |
| response to alcohol | GO:0097305 | 48 | 0.028 | |
| heart morphogenesis | GO:0003007 | 178 | 0.028 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.027 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.027 | |
| skin development | GO:0043588 | 220 | 0.027 | |
| germline cell cycle switching mitotic to meiotic cell cycle | GO:0051729 | 1 | 0.027 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.027 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.027 | |
| intracellular protein transport | GO:0006886 | 204 | 0.026 | |
| chromatin mediated maintenance of transcription | GO:0048096 | 2 | 0.026 | |
| microtubule anchoring at microtubule organizing center | GO:0072393 | 5 | 0.026 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.026 | |
| learning | GO:0007612 | 98 | 0.026 | |
| spermatogenesis | GO:0007283 | 284 | 0.026 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.026 | |
| placenta development | GO:0001890 | 140 | 0.026 | |
| limb development | GO:0060173 | 166 | 0.026 | |
| compound eye development | GO:0048749 | 1 | 0.025 | |
| body morphogenesis | GO:0010171 | 45 | 0.025 | |
| protein acylation | GO:0043543 | 64 | 0.025 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.025 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.025 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.025 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.025 | |
| regulation of cell motility | GO:2000145 | 236 | 0.025 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.025 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.025 | |
| neural tube development | GO:0021915 | 160 | 0.025 | |
| regulation of ossification | GO:0030278 | 112 | 0.024 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.024 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.024 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.024 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.024 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.024 | |
| protein methylation | GO:0006479 | 81 | 0.024 | |
| striated muscle cell development | GO:0055002 | 125 | 0.023 | |
| liver development | GO:0001889 | 66 | 0.023 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.023 | |
| organelle fission | GO:0048285 | 170 | 0.023 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.023 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.023 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.023 | |
| positive regulation of myeloid cell apoptotic process | GO:0033034 | 4 | 0.023 | |
| atp metabolic process | GO:0046034 | 75 | 0.022 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.022 | |
| atp catabolic process | GO:0006200 | 55 | 0.022 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.022 | |
| response to growth factor | GO:0070848 | 198 | 0.022 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.022 | |
| cell cycle switching mitotic to meiotic cell cycle | GO:0051728 | 1 | 0.022 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.022 | |
| rna 3 end processing | GO:0031123 | 20 | 0.022 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.022 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.022 | |
| epithelial cell development | GO:0002064 | 159 | 0.022 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.022 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.022 | |
| microtubule based process | GO:0007017 | 236 | 0.022 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.022 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.021 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.021 | |
| positive regulation of meiotic cell cycle | GO:0051446 | 15 | 0.021 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.021 | |
| chromatin modification | GO:0016568 | 187 | 0.021 | |
| lipid localization | GO:0010876 | 126 | 0.021 | |
| chromatin silencing | GO:0006342 | 15 | 0.021 | |
| cellular homeostasis | GO:0019725 | 240 | 0.021 | |
| connective tissue development | GO:0061448 | 179 | 0.021 | |
| oogenesis | GO:0048477 | 56 | 0.021 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.021 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.020 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.020 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.020 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.020 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.020 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.020 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.020 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.019 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.019 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.019 | |
| response to osmotic stress | GO:0006970 | 21 | 0.019 | |
| cellular response to lipid | GO:0071396 | 145 | 0.019 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.019 | |
| respiratory tube development | GO:0030323 | 167 | 0.019 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.019 | |
| lung development | GO:0030324 | 164 | 0.019 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.019 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.019 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.019 | |
| circadian rhythm | GO:0007623 | 114 | 0.019 | |
| amide transport | GO:0042886 | 138 | 0.019 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.018 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.018 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.018 | |
| segmentation | GO:0035282 | 93 | 0.018 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.018 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.018 | |
| epidermis development | GO:0008544 | 187 | 0.018 | |
| epithelial tube formation | GO:0072175 | 130 | 0.018 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.018 | |
| myotube differentiation | GO:0014902 | 105 | 0.018 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.018 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.018 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.018 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.018 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.018 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.018 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.018 | |
| ear development | GO:0043583 | 200 | 0.018 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.018 | |
| muscle fiber development | GO:0048747 | 76 | 0.017 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.017 | |
| oxidation reduction process | GO:0055114 | 342 | 0.017 | |
| mesenchyme development | GO:0060485 | 152 | 0.017 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.017 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.017 | |
| regulation of protein transport | GO:0051223 | 163 | 0.017 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.017 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.017 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.017 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.017 | |
| synapse organization | GO:0050808 | 125 | 0.017 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.017 | |
| endocytosis | GO:0006897 | 168 | 0.017 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.017 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.017 | |
| regulation of cell activation | GO:0050865 | 289 | 0.017 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.016 | |
| embryonic placenta development | GO:0001892 | 98 | 0.016 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.016 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.016 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.016 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.016 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.016 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.016 | |
| immune effector process | GO:0002252 | 321 | 0.016 | |
| peptide transport | GO:0015833 | 133 | 0.016 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.016 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.016 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.016 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.016 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.016 | |
| myotube cell development | GO:0014904 | 60 | 0.016 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.016 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.016 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.016 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.016 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.016 | |
| axonogenesis | GO:0007409 | 274 | 0.016 | |
| sensory perception | GO:0007600 | 245 | 0.015 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.015 | |
| regulation of translation | GO:0006417 | 71 | 0.015 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.015 | |
| peptide secretion | GO:0002790 | 114 | 0.015 | |
| protein ubiquitination | GO:0016567 | 171 | 0.015 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.015 | |
| defecation | GO:0030421 | 1 | 0.015 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.015 | |
| response to hydroperoxide | GO:0033194 | 6 | 0.015 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.015 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.015 | |
| tolerance induction to self antigen | GO:0002513 | 4 | 0.015 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.015 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.015 | |
| regulation of protein processing | GO:0070613 | 96 | 0.015 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.015 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.015 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.015 | |
| protein targeting | GO:0006605 | 143 | 0.015 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.015 | |
| renal system development | GO:0072001 | 225 | 0.015 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.015 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.015 | |
| response to peptide | GO:1901652 | 136 | 0.015 | |
| regulation of organ growth | GO:0046620 | 61 | 0.015 | |
| muscle contraction | GO:0006936 | 101 | 0.015 | |
| calcium ion transport | GO:0006816 | 159 | 0.015 | |
| cellular response to radiation | GO:0071478 | 28 | 0.015 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.015 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.014 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.014 | |
| female sex differentiation | GO:0046660 | 84 | 0.014 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.014 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.014 | |
| innate immune response | GO:0045087 | 157 | 0.014 | |
| cell cycle switching | GO:0060184 | 1 | 0.014 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.014 | |
| natural killer cell differentiation | GO:0001779 | 21 | 0.014 | |
| response to peptide hormone | GO:0043434 | 127 | 0.014 | |
| lateral inhibition | GO:0046331 | 1 | 0.014 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.014 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.014 | |
| granulocyte differentiation | GO:0030851 | 17 | 0.014 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.014 | |
| primary neural tube formation | GO:0014020 | 95 | 0.014 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.014 | |
| blastocyst development | GO:0001824 | 80 | 0.014 | |
| v d j recombination | GO:0033151 | 14 | 0.014 | |
| maintenance of location | GO:0051235 | 89 | 0.014 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.014 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.014 | |
| heart valve development | GO:0003170 | 23 | 0.014 | |
| central nervous system neuron axonogenesis | GO:0021955 | 28 | 0.014 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.014 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.014 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.014 | |
| dna methylation | GO:0006306 | 43 | 0.014 | |
| exocytosis | GO:0006887 | 121 | 0.013 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.013 | |
| cell chemotaxis | GO:0060326 | 81 | 0.013 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.013 | |
| actin filament polymerization | GO:0030041 | 44 | 0.013 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.013 | |
| nuclear transcribed mrna catabolic process | GO:0000956 | 16 | 0.013 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.013 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.013 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.013 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.013 | |
| response to drug | GO:0042493 | 75 | 0.013 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.013 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.013 | |
| oocyte axis specification | GO:0007309 | 2 | 0.013 | |
| cation transport | GO:0006812 | 399 | 0.013 | |
| b cell activation | GO:0042113 | 161 | 0.013 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.013 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.013 | |
| transmembrane transport | GO:0055085 | 412 | 0.013 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.013 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.013 | |
| cytoplasmic mrna processing body assembly | GO:0033962 | 6 | 0.013 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.013 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.013 | |
| response to radiation | GO:0009314 | 165 | 0.013 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.013 | |
| response to inorganic substance | GO:0010035 | 96 | 0.013 | |
| muscle adaptation | GO:0043500 | 39 | 0.013 | |
| phagocytosis | GO:0006909 | 66 | 0.012 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.012 | |
| digestive tract development | GO:0048565 | 190 | 0.012 | |
| hair cycle | GO:0042633 | 90 | 0.012 | |
| mrna catabolic process | GO:0006402 | 22 | 0.012 | |
| rna processing | GO:0006396 | 105 | 0.012 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.012 | |
| phosphatidylinositol biosynthetic process | GO:0006661 | 15 | 0.012 | |
| genitalia development | GO:0048806 | 37 | 0.012 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.012 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.012 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.012 | |
| adaptive immune response | GO:0002250 | 155 | 0.012 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.012 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.012 | |
| male gamete generation | GO:0048232 | 285 | 0.012 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.012 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.012 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.012 | |
| positive regulation of muscle adaptation | GO:0014744 | 2 | 0.012 | |
| activation of immune response | GO:0002253 | 138 | 0.012 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.012 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.012 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.012 | |
| palate development | GO:0060021 | 76 | 0.012 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.012 | |
| dephosphorylation | GO:0016311 | 129 | 0.012 | |
| protein maturation | GO:0051604 | 176 | 0.012 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.012 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.012 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.012 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.012 | |
| locomotory behavior | GO:0007626 | 195 | 0.012 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.012 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.012 | |
| molting cycle | GO:0042303 | 90 | 0.012 | |
| myoblast differentiation | GO:0045445 | 52 | 0.012 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.012 | |
| pancreas development | GO:0031016 | 57 | 0.011 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.011 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.011 | |
| negative regulation of protein catabolic process | GO:0042177 | 36 | 0.011 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.011 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.011 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.011 | |
| histone lysine methylation | GO:0034968 | 50 | 0.011 | |
| cartilage development | GO:0051216 | 140 | 0.011 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.011 | |
| neurotransmitter secretion | GO:0007269 | 62 | 0.011 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.011 | |
| positive regulation of intracellular protein transport | GO:0090316 | 42 | 0.011 | |
| peptidyl threonine phosphorylation | GO:0018107 | 31 | 0.011 | |
| dendrite development | GO:0016358 | 115 | 0.011 | |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.011 | |
| rna catabolic process | GO:0006401 | 29 | 0.011 | |
| mrna metabolic process | GO:0016071 | 84 | 0.011 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.011 | |
| endoderm development | GO:0007492 | 45 | 0.011 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.011 | |
| body fluid secretion | GO:0007589 | 53 | 0.011 | |
| phosphatidylinositol 3 phosphate biosynthetic process | GO:0036092 | 6 | 0.011 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.011 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.011 | |
| regulation of cell migration | GO:0030334 | 219 | 0.011 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.011 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.011 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.011 | |
| viral gene expression | GO:0019080 | 3 | 0.011 | |
| insulin secretion | GO:0030073 | 89 | 0.011 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.010 | |
| actin filament based movement | GO:0030048 | 23 | 0.010 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.010 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.010 | |
| male sex differentiation | GO:0046661 | 109 | 0.010 | |
| associative learning | GO:0008306 | 61 | 0.010 | |
| cellular response to peptide | GO:1901653 | 92 | 0.010 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.010 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.010 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.010 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.010 | |
| midgut development | GO:0007494 | 4 | 0.010 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.010 | |
| rna interference | GO:0016246 | 2 | 0.010 | |
| membrane depolarization | GO:0051899 | 64 | 0.010 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.010 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.010 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.010 | |
| regulation of wound healing | GO:0061041 | 40 | 0.010 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.010 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.010 | |
